Prognostic Role of Dynamic Neutrophil-to-lymphocyte Ratio in Acute Ischemic Stroke After Reperfusion Therapy: A Meta-analysis

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Mar 6

PMID 36873451

Authors

Bing Wu

Fang Liu

Guiyan Sun

Shuang Wang

Affiliations

Soon will be listed here.

Abstract

Background: The prognostic role of the neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, in acute ischemic stroke (AIS) after reperfusion therapy remains controversial. Therefore, this meta-analysis sought to assess the correlation between the dynamic NLR and the clinical outcomes of patients with AIS after reperfusion therapy.

Methods: PubMed, Web of Science, and Embase databases were searched to identify relevant literature from their inception to 27 October 2022. The clinical outcomes of interest included poor functional outcome (PFO) at 3 months, symptomatic intracerebral hemorrhage (sICH), and 3-month mortality. The NLR on admission (pre-treatment) and post-treatment was collected. The PFO was defined as a modified Rankin scale (mRS) of >2.

Results: A total of 17,232 patients in 52 studies were included in the meta-analysis. The admission NLR was higher in the 3-month PFO (standardized mean difference [SMD] = 0.46, 95% confidence interval [CI] = 0.35-0.57), sICH (SMD = 0.57, 95% CI = 0.30-0.85), and mortality at 3 months (SMD = 0.60, 95% CI = 0.34-0.87). An elevated admission NLR was associated with an increased risk of 3-month PFO (odds ratio [OR] = 1.13, 95% CI = 1.09-1.17), sICH (OR = 1.11, 95% CI = 1.06-1.16), and mortality at 3 months (OR = 1.13, 95% CI = 1.07-1.20). The post-treatment NLR was significantly higher in the 3-month PFO (SMD = 0.80, 95% CI = 0.62-0.99), sICH (SMD = 1.54, 95% CI = 0.97-2.10), and mortality at 3 months (SMD = 1.00, 95% CI = 0.31-1.69). An elevated post-treatment NLR was significantly associated with an increased risk of 3-month PFO (OR = 1.25, 95% CI = 1.16-1.35), sICH (OR = 1.14, 95% CI = 1.01-1.29), and mortality at 3 months (OR = 1.28, 95% CI = 1.09-1.50).

Conclusion: The admission and post-treatment NLR can be used as cost-effective and easily available biomarkers to predict the 3-month PFO, sICH, and mortality at 3 months in patients with AIS treated with reperfusion therapy. The post-treatment NLR provides better predictive power than the admission NLR.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier: CRD42022366394.

Citing Articles

Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression.

Martinis L, Castiglia S, Vaghi G, Morotti A, Grillo V, Corrado M Sensors (Basel). 2024; 24(18).

PMID: 39338758 PMC: 11435490. DOI: 10.3390/s24186012.

Postoperative neutrophil-to-lymphocyte ratio predicts malignant cerebral edema following endovascular treatment for acute ischemic stroke.

Zheng S, Jiang X, Guo S, Shi Z Front Neurol. 2024; 15:1394550.

PMID: 38994493 PMC: 11236612. DOI: 10.3389/fneur.2024.1394550.

Systemic-inflammatory indices and clinical outcomes in patients with anterior circulation acute ischemic stroke undergoing successful endovascular thrombectomy.

Cao W, Song Y, Bai X, Yang B, Li L, Wang X Heliyon. 2024; 10(10):e31122.

PMID: 38778990 PMC: 11109896. DOI: 10.1016/j.heliyon.2024.e31122.

Prognostic value of neutrophil-to-lymphocyte ratio dynamics in patients with septic acute kidney injury: a cohort study.

Wei W, Liu C, Song G, Yang L, Li J, Wang B Ren Fail. 2024; 46(1):2343818.

PMID: 38637281 PMC: 11028010. DOI: 10.1080/0886022X.2024.2343818.

The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting.

Vaghi G, Morotti A, Piella E, Avenali M, Martinelli D, Cristina S Sci Rep. 2024; 14(1):8320.

PMID: 38594322 PMC: 11003970. DOI: 10.1038/s41598-024-58562-1.

References

Kim T, Park S, Ko S . Dynamic change of neutrophil-to-lymphocyte ratio and symptomatic intracerebral hemorrhage after endovascular recanalization therapy. J Stroke Cerebrovasc Dis. 2022; 31(9):106604. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106604. View

Sadeghi F, Sarkady F, Zsori K, Szegedi I, Orban-Kalmandi R, Szekely E . High Neutrophil-Lymphocyte Ratio and Low Lymphocyte-Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke. J Pers Med. 2022; 12(8). PMC: 9332832. DOI: 10.3390/jpm12081221. View

Otxoa-de-Amezaga A, Gallizioli M, Pedragosa J, Justicia C, Miro-Mur F, Salas-Perdomo A . Location of Neutrophils in Different Compartments of the Damaged Mouse Brain After Severe Ischemia/Reperfusion. Stroke. 2019; 50(6):1548-1557. DOI: 10.1161/STROKEAHA.118.023837. View

Maestrini I, Strbian D, Gautier S, Haapaniemi E, Moulin S, Sairanen T . Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes. Neurology. 2015; 85(16):1408-16. PMC: 4626239. DOI: 10.1212/WNL.0000000000002029. View

Wang C, Zhang Q, Ji M, Mang J, Xu Z . Prognostic value of the neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis. BMC Neurol. 2021; 21(1):191. PMC: 8111766. DOI: 10.1186/s12883-021-02222-8. View

Jayaraj R, Azimullah S, Beiram R, Jalal F, Rosenberg G . Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019; 16(1):142. PMC: 6617684. DOI: 10.1186/s12974-019-1516-2. View

Shi J, Peng H, You S, Liu Y, Xu J, Xu Y . Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study. Eur J Neurol. 2018; 25(4):687-e45. DOI: 10.1111/ene.13575. View

Liao M, Li F, Hu J, Yang J, Wu D, Xie D . High neutrophil counts before endovascular treatment for acute basilar artery occlusion predict worse outcomes. Front Aging Neurosci. 2022; 14:978740. PMC: 9475290. DOI: 10.3389/fnagi.2022.978740. View

Majid S, Ul Haq Lodhi O, Niazi A, Lodhi S, Siddiqui M . Usefulness of neutrophil-to-lymphocyte ratio as a predictor of functional outcome in patients with acute ischemic stroke after thrombolysis therapy. Proc (Bayl Univ Med Cent). 2021; 34(6):664-667. PMC: 8545156. DOI: 10.1080/08998280.2021.1938471. View

10.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

11.

Hu D, Ding C, Jiang X, Xiao J, Li C, Zhang L . Elevated Levels of Inflammation Markers Predict Poor Outcomes in Acute Ischemic Stroke Patients After Intravenous Thrombolysis. J Stroke Cerebrovasc Dis. 2021; 30(3):105587. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105587. View

12.

Li F, Ren Y, Cui X, Liu P, Chen F, Zhao H . Postoperative hyperglycemia predicts symptomatic intracranial hemorrhage after endovascular treatment in patients with acute anterior circulation large artery occlusion. J Neurol Sci. 2019; 409:116588. DOI: 10.1016/j.jns.2019.116588. View

13.

Liu Y, Wu Z, Qu J, Qiu D, Luo G, Yin H . High neutrophil-to-lymphocyte ratio is a predictor of poor short-term outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis. Brain Behav. 2020; 10(12):e01857. PMC: 7749577. DOI: 10.1002/brb3.1857. View

14.

Gao B, Pan W, Hu X, Huang H, Ren J, Yang C . Neutrophil-Related Ratios Predict the 90-Day Outcome in Acute Ischemic Stroke Patients After Intravenous Thrombolysis. Front Physiol. 2021; 12:670323. PMC: 8283126. DOI: 10.3389/fphys.2021.670323. View

15.

Albers G, Marks M, Kemp S, Christensen S, Tsai J, Ortega-Gutierrez S . Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018; 378(8):708-718. PMC: 6590673. DOI: 10.1056/NEJMoa1713973. View

16.

Ferro D, Matias M, Neto J, Dias R, Moreira G, Petersen N . Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke. Stroke. 2021; 52(3):859-867. DOI: 10.1161/STROKEAHA.120.032130. View

17.

Ying A, Cheng Y, Lin Y, Yu J, Wu X, Lin Y . Dynamic increase in neutrophil levels predicts parenchymal hemorrhage and function outcome of ischemic stroke with r-tPA thrombolysis. Neurol Sci. 2020; 41(8):2215-2223. DOI: 10.1007/s10072-020-04324-6. View

18.

Xie X, Yang J, Ren L, Hu S, Lian W, Xiao J . Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population. Curr Neurovasc Res. 2021; 18(5):543-551. DOI: 10.2174/1567202619666211223150907. View

19.

Luo D, Wan X, Liu J, Tong T . Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2016; 27(6):1785-1805. DOI: 10.1177/0962280216669183. View

20.

Rao N, Levine S, Gornbein J, Saver J . Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials. Stroke. 2014; 45(9):2728-33. PMC: 4154062. DOI: 10.1161/STROKEAHA.114.005135. View